Anti-CD25 monoclonal antibody coverage allows for calcineurin inhibitor "holiday" in solid organ transplant patients with acute renal dysfunction

Transplantation

Volumn 73, Issue 7, 2002, Pages 1169-1172

  Cantarovich, Marcelo ^a   Metrakos, Peter ^a   Giannetti, Nadia ^a   Cecere, Renzo ^a   Barkun, Jeffrey ^a   Tchervenkov, Jean ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CELL CEPT; CREATININE; CYCLOSPORIN A; INTERLEUKIN 2 RECEPTOR ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DRUG TOLERABILITY; DRUG WITHDRAWAL; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; KIDNEY DYSFUNCTION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0037090873     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200204150-00030     Document Type: Article

References (13)

1. Interleukin-2 receptor blockade with daclizumab to prevent acute rejection in renal transplantation
2. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients
3. Cyclosporine A in patients receiving renal allografts from cadaver donors
4. Effects of renal impairment on liver transplantation
5. Acute renal failure after heart transplantation and cyclosporine therapy
6. Can antibody prophylaxis allow sparing of other immunosuppressives?
7. A calcineurin-free strategy for induction immunosuppression for delayed graft function in cadaveric kidney transplantation
8. A calcineurin inhibitor-sparing regimen with sirolimus, mycophenolate mofetil, and anti-CD25 mAb provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft function
9. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group
10. Cyclosporine-induced acute renal dysfunction in the rat. Evidence of arteriolar vasoconstriction with preservation of tubular function
11. Population pharmacokinetics and exposure-response relationships for basiliximab in kidney transplantation
12. A phase I trial of humanized anti-interleukin-2 receptor antibody in renal transplantation